View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMusclePharm 배당 및 자사주 매입배당 기준 점검 0/6MusclePharm 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.공시 • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.공시 • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.공시 • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.공시 • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.공시 • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jul 29+ 1 more updateMusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the CompanyMusclePharm Corporation announced that on July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company. Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018. Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.공시 • Jul 13+ 1 more updateSabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.공시 • Jul 07MusclePharm Announces the Launch of FitMiss EnergyMusclePharm Corporation announced the launch of FitMiss Energy, a ready-to-drink, zero-calorie functional energy beverage featuring 450mg of Branched Chain Amino Acids (“BCAA”), 200mg of caffeine, and 100% recommended dietary intake (“RDI”) of Biotin per can in three refreshing flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. The MusclePharm FitMiss brand has been a leader in the female performance segment, with FitMiss Delight, for the last 5 years. Building onto the FitMiss brand family, FitMiss Energy features no artificial colorings or flavorings and is available in competitively priced, 12-can cases of a single flavor or a variety-pack format exclusively on Amazon.공시 • Jun 24Musclepharm Corporation Appoints Eric Chin as Chief Accounting OfficerMusclePharm Corporation announced that effective as of June 17, 2022 the company appointed Mr. Eric Chin as the Company’s Chief Accounting Officer. Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015, he served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.공시 • Jun 15MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of DirectorsMusclePharm Corporation announced that effective June 10, 2022, the company appointed Sabina Rizvi, the Company’s President and Chief Financial Officer, as a member of the board of directors of the Company. Sabina Rizvi has served as the Company’s President and Chief Financial Officer since April 2021. Previously, Ms. Rizvi held multiple C-suite roles at Yum! Brands, with increasing responsibility including CFO of the Canadian and Thailand business units and President and General Manager of Pizza Hut Thailand, where she oversaw significant growth of the brand. Most recently, she was Chief Operating Officer, Yum! Digital and Technology, playing an instrumental role in leveraging technology to transform the customer experience. Ms. Rizvi graduated from University of Windsor, Canada with a Master of Business Administration and completed her Honors Bachelor of Mathematics from University of Waterloo, Canada. The Company believes Ms. Rizvi is qualified to serve as a member of the Company’s board of directors because of the aforementioned experience and the breadth of her management responsibilities with the Company.공시 • May 12MusclePharm Corporation to Report Q1, 2022 Results on May 16, 2022MusclePharm Corporation announced that they will report Q1, 2022 results After-Market on May 16, 2022공시 • Apr 13MusclePharm Corporation to Report Q4, 2021 Results on Apr 14, 2022MusclePharm Corporation announced that they will report Q4, 2021 results After-Market on Apr 14, 2022공시 • Apr 01+ 1 more updateMusclePharm Corporation announced delayed annual 10-K filingOn 03/31/2022, MusclePharm Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.공시 • Feb 08MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USMusclePharm Corporation announced the expansion of its product line with Costco U.S with the roll out of its reformulated MP Combat Protein Powder in a newly sized tub. The reformulated product has an improved taste and mixability factor and is now being sold in Costco U.S in a recyclable, 6.2-liter tub. The new product will be part of a promotion running in all Costco U.S stores this March with samples available for customers to try out the new taste.공시 • May 18MusclePharm Corporation announced delayed 10-Q filingOn 05/17/2021, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.공시 • Jan 22Musclepharm Appoints Michael Heller to Its Board of DirectorsMusclePharm Corporation announced that it has appointed Michael Heller to its Board of Directors. Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party.공시 • Jan 09William Bush Submits Resignation from the Board of Directors of MusclePharm Corporation and All CommitteesOn December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 MSLP.Q 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: MSLP.Q 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장MusclePharm 배당 수익률 vs 시장MSLP.Q의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (MSLP.Q)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Personal Products)3.2%분석가 예측 (MSLP.Q) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 MSLP.Q 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 MSLP.Q 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 MSLP.Q 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: MSLP.Q 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/03/08 19:35종가2025/03/05 00:00수익2022/03/31연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MusclePharm Corporation는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Edward WooAscendiant Capital Markets LLCJack WallaceSidoti & Company, LLC
공시 • Sep 29FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.FitLife Brands, Inc. (NasdaqCM:FTLF) entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million on September 5, 2023. The Purchase Price is subject to adjustment and is expected to be funded from available cash and the proceeds from a committed $10.0 million term loan from First Citizens Bank with an interest rate equal to the SOFR (secured overnight financing rate) plus 275 basis points. On September 21, 2023, the U.S. Bankruptcy Court for the District of Nevada approved the transaction. Closing of the sale will occur on or before October 16, 2023. Samuel A. Schwartz of Schwartz Law, PLLC acted as legal advisor to MusclePharm. Todd Feinsmith of Troutman Pepper Hamilton Sanders LLP acted as legal advisor to FitLife Brands.
공시 • Sep 01Musclepharm Corporation Announces Resignation of Paul Karr as DirectorEffective as of August 9, 2023, Paul Karr resigned as director MusclePharm Corporation. Mr. Karr’s resignation from the Board of Directors of the Company did not result from any disagreement with the Company.
공시 • Jul 22Musclepharm Corporation Terminates Gary Shirshac as Chief Financial OfficerEffective as of July 10, 2023, MusclePharm Corporation terminated Chief Financial Officer, Gary Shirshac. There are no family relationships between Mr. Shirshac and any other director or officer of the Company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Separately, on December 15, 2022, the Company filed for protection under Chapter 11 of the United States Bankruptcy Code before the United States Bankruptcy Court for the District of Nevada, Case No. 22-14422 – NMC. Attached hereto are copies of the Monthly Operating Reports filed in the bankruptcy case.
공시 • Dec 16MusclePharm Corporation Filed for BankruptcyMusclePharm Corporation filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Nevada on December 15, 2022. The debtor listed both its assets and liabilities in the range of $10 million to $50 million. The debtor is represented by Samuel A. Schwartz of Schwartz Law, PLLC as its legal counsel.
공시 • Sep 30MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial OfficerOn September 26, 2022, MusclePharm Corporation appointed Gary C. Shirshac to serve as interim chief financial officer. There are no family relationships between Mr. Shirshac and any other director or officer of the company. There are no transactions in which Mr. Shirshac has an interest requiring disclosure under Item 404(a) of Regulation S-K. Set forth below is the biographical information of Mr. Shirshac, as required by Item 401 of Regulation S-K. Mr. Shirshac’s base salary is $250,000 and he will be eligible to participate in the company’s benefits plan as of October 1, 2022. Prior to joining the company, Mr. Shirshac, 60, served as the chief financial officer and on the board of Directors of Newpoint Financial Corporation from 2020 to February 2022. Prior to that, Mr. Shirshac served as the Chief Financial Officer and Managing Director of GCS Consulting from 2013 to 2019. Mr. Shirshac’s work experience prior to that included accounting, tax and SEC compliance work in-house, as a consultant and in national accounting firms. Mr. Shirshac is a Certified Public Accountant and received his BS Accountancy from Villanova University.
공시 • Aug 18MusclePharm Corporation announced delayed 10-Q filingOn 08/17/2022, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jul 29+ 1 more updateMusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the CompanyMusclePharm Corporation announced that on July 28, 2022, the Board of Directors appointed Eric Chin as Chief Financial Officer of the Company. There are no family relationships between Mr. Chin and any other director or officer of the Company. Mr. Chin, joined the Company in June 2022 as Chief Accounting Officer. Prior to that, Mr. Chin served as the Chief Financial Officer of Apollo Medical Holdings Inc. from 2018 to May 2022. Prior to that, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage from 2015 to 2018. Mr. Chin served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. from 2011 to 2015. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant and received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.
공시 • Jul 13+ 1 more updateSabina Rizvi Notifies MusclePharm Corporation of Her Resignation as President, Effective July 22, 2022On July 6, 2022, Sabina Rizvi notified the Board of Directors of MusclePharm Corporation of her resignation as President of the Company, effective July 22, 2022.
공시 • Jul 07MusclePharm Announces the Launch of FitMiss EnergyMusclePharm Corporation announced the launch of FitMiss Energy, a ready-to-drink, zero-calorie functional energy beverage featuring 450mg of Branched Chain Amino Acids (“BCAA”), 200mg of caffeine, and 100% recommended dietary intake (“RDI”) of Biotin per can in three refreshing flavors: Pineapple Coco, Mango Sunshine, and Watermelon Waterfall. The MusclePharm FitMiss brand has been a leader in the female performance segment, with FitMiss Delight, for the last 5 years. Building onto the FitMiss brand family, FitMiss Energy features no artificial colorings or flavorings and is available in competitively priced, 12-can cases of a single flavor or a variety-pack format exclusively on Amazon.
공시 • Jun 24Musclepharm Corporation Appoints Eric Chin as Chief Accounting OfficerMusclePharm Corporation announced that effective as of June 17, 2022 the company appointed Mr. Eric Chin as the Company’s Chief Accounting Officer. Mr. Chin, age 42, joins the Company from Apollo Medical Holdings Inc., where he served as Chief Financial Officer. From 2015 to 2018, Mr. Chin served as the Controller/Head of Finance - Real Estate of Public Storage. From 2011 to 2015, he served as Assistant Vice-President - Financial Reporting of Alexandria Real Estate Equities Inc. Mr. Chin began his career at Ernst & Young, LLP in 2002. Mr. Chin is a Certified Public Accountant. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.
공시 • Jun 15MusclePharm Corporation Appoints Sabina Rizvi as Member of the Board of DirectorsMusclePharm Corporation announced that effective June 10, 2022, the company appointed Sabina Rizvi, the Company’s President and Chief Financial Officer, as a member of the board of directors of the Company. Sabina Rizvi has served as the Company’s President and Chief Financial Officer since April 2021. Previously, Ms. Rizvi held multiple C-suite roles at Yum! Brands, with increasing responsibility including CFO of the Canadian and Thailand business units and President and General Manager of Pizza Hut Thailand, where she oversaw significant growth of the brand. Most recently, she was Chief Operating Officer, Yum! Digital and Technology, playing an instrumental role in leveraging technology to transform the customer experience. Ms. Rizvi graduated from University of Windsor, Canada with a Master of Business Administration and completed her Honors Bachelor of Mathematics from University of Waterloo, Canada. The Company believes Ms. Rizvi is qualified to serve as a member of the Company’s board of directors because of the aforementioned experience and the breadth of her management responsibilities with the Company.
공시 • May 12MusclePharm Corporation to Report Q1, 2022 Results on May 16, 2022MusclePharm Corporation announced that they will report Q1, 2022 results After-Market on May 16, 2022
공시 • Apr 13MusclePharm Corporation to Report Q4, 2021 Results on Apr 14, 2022MusclePharm Corporation announced that they will report Q4, 2021 results After-Market on Apr 14, 2022
공시 • Apr 01+ 1 more updateMusclePharm Corporation announced delayed annual 10-K filingOn 03/31/2022, MusclePharm Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
공시 • Feb 08MusclePharm Rolls Out New and Improved MP Combat Protein Powder to Costco USMusclePharm Corporation announced the expansion of its product line with Costco U.S with the roll out of its reformulated MP Combat Protein Powder in a newly sized tub. The reformulated product has an improved taste and mixability factor and is now being sold in Costco U.S in a recyclable, 6.2-liter tub. The new product will be part of a promotion running in all Costco U.S stores this March with samples available for customers to try out the new taste.
공시 • May 18MusclePharm Corporation announced delayed 10-Q filingOn 05/17/2021, MusclePharm Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
공시 • Jan 22Musclepharm Appoints Michael Heller to Its Board of DirectorsMusclePharm Corporation announced that it has appointed Michael Heller to its Board of Directors. Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party.
공시 • Jan 09William Bush Submits Resignation from the Board of Directors of MusclePharm Corporation and All CommitteesOn December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof.